DK0916663T3 - 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........ - Google Patents

18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........

Info

Publication number: DK0916663T3
Authority: DK; Denmark
Prior art keywords: esculentin; diacetyloxy; epoxy; 19beta; 18alpha
Prior art date: 1997-11-18

Application number

DK98121657T

Other languages

English (en)

Inventor

Swati Dr Bal-Tembe

Kumar Erra Koteswara Sa Vijaya

Deore Vijay Dipex-Kira Bhagwan

Joshi Kalpana Dr Sanjay

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-18

Filing date

1998-11-12

Publication date

2003-07-28

1998-11-12 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2003-07-28 Application granted granted Critical

2003-07-28 Publication of DK0916663T3 publication Critical patent/DK0916663T3/da

Links

VXDGLMKJOZOWRO-UHFFFAOYSA-N esculentin A Natural products O=C1CC2C(CCC(=C)C=C)(C)C(C)CCC32C(OC(C)=O)OC(OC(C)=O)C3=C1 VXDGLMKJOZOWRO-UHFFFAOYSA-N 0.000 title abstract 4
LPSTZZWXOOHMOA-UHFFFAOYSA-N esculentin B Natural products OC1C(O)C(C)C(CC=C(C)C=C)(C)C2C31C(OC(C)=O)OC(OC(C)=O)C3=CC(OC(=O)CC(C)C)C2 LPSTZZWXOOHMOA-UHFFFAOYSA-N 0.000 title abstract 3
LPSTZZWXOOHMOA-OZUCLCINSA-N [(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3-diacetyloxy-9,10-dihydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dienyl]-1,3,5,6,6a,8,9,10-octahydrobenzo[d][2]benzofuran-5-yl] 3-methylbutanoate Chemical compound [C@H]1([C@]([C@H](C)[C@@H](O)[C@@H]2O)(C)C\C=C(\C)C=C)[C@]32[C@H](OC(C)=O)O[C@H](OC(C)=O)C3=C[C@H](OC(=O)CC(C)C)C1 LPSTZZWXOOHMOA-OZUCLCINSA-N 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
241000169616 Casearia Species 0.000 abstract 1
241000196324 Embryophyta Species 0.000 abstract 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Furan Compounds (AREA)
Epoxy Compounds (AREA)
Steroid Compounds (AREA)

DK98121657T 1997-11-18 1998-11-12 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........ DK0916663T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97120143		1997-11-18

Publications (1)

Publication Number	Publication Date
DK0916663T3 true DK0916663T3 (da)	2003-07-28

Family

ID=8227636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98121657T DK0916663T3 (da)	1997-11-18	1998-11-12	18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........

Country Status (8)

Country	Link
US (1)	US6107335A (da)
EP (1)	EP0916663B1 (da)
JP (1)	JP4373510B2 (da)
AT (1)	ATE239715T1 (da)
DE (1)	DE69814307T2 (da)
DK (1)	DK0916663T3 (da)
ES (1)	ES2198631T3 (da)
PT (1)	PT916663E (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2575613C (en) *	2004-08-04	2015-05-19	Foam Supplies, Inc.	Reactivity drift and catalyst degradation in polyurethane foam
CN104418829A (zh) *	2013-09-07	2015-03-18	山东大学（威海）	一种具有抗肿瘤作用的化合物单叶蔓荆素b的结构与制备方法及其用途
CN112239439A (zh) *	2019-07-17	2021-01-19	南开大学	四种具有抗癌活性的烈味脚骨脆二萜的制备方法和用途
IT201900018938A1 (it)	2019-10-16	2021-04-16	Univ Degli Studi Roma La Sapienza	Uso di esculentina e suoi derivati per uso per il trattamento della fibrosi cistica

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5468772A (en) *	1993-03-10	1995-11-21	Pharmagenesis, Inc.	Tripterinin compound and method

1998
- 1998-11-12 DE DE69814307T patent/DE69814307T2/de not_active Expired - Lifetime
- 1998-11-12 DK DK98121657T patent/DK0916663T3/da active
- 1998-11-12 EP EP98121657A patent/EP0916663B1/en not_active Expired - Lifetime
- 1998-11-12 PT PT98121657T patent/PT916663E/pt unknown
- 1998-11-12 ES ES98121657T patent/ES2198631T3/es not_active Expired - Lifetime
- 1998-11-12 AT AT98121657T patent/ATE239715T1/de not_active IP Right Cessation
- 1998-11-17 US US09/192,501 patent/US6107335A/en not_active Expired - Lifetime
- 1998-11-17 JP JP32647698A patent/JP4373510B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69814307T2 (de)	2004-07-01
ES2198631T3 (es)	2004-02-01
EP0916663B1 (en)	2003-05-07
PT916663E (pt)	2003-09-30
DE69814307D1 (de)	2003-06-12
US6107335A (en)	2000-08-22
ATE239715T1 (de)	2003-05-15
JPH11236383A (ja)	1999-08-31
JP4373510B2 (ja)	2009-11-25
EP0916663A1 (en)	1999-05-19

Similar Documents

Publication	Publication Date	Title
RU93005350A (ru)	1996-07-20	Новые замещенные фенилимидазолидины, способ их получения, их применение в качестве медикаментов и включающие их фармацевтические соединения
FI931226A7 (fi)	1993-03-19	Hitaasti vapautuvia koostumuksia periodontaalisen sairauden hoitamisek si
FI942074A0 (fi)	1994-05-05	nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
DE3769174D1 (de)	1991-05-16	Indolizin-derivate, verfahren zur herstellung und diese enthaltende zusammensetzungen.
ATE104271T1 (de)	1994-04-15	2-(2-hydroxy-3phenoxypropylamino)ethylphenoxyacetamide, verfahren und zwischenprodukte zu deren herstellung.
FI920023A0 (fi)	1992-01-03	Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
FR2703051B1 (fr)	1995-04-28	Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
DE3877406D1 (de)	1993-02-25	Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
NO303783B1 (no)	1998-08-31	Substituerte aminofosfonatderivater og farmas°ytiske preparater derav
FI903759A0 (fi)	1990-07-27	Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.
DK0400522T3 (da)	1995-04-03	Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
DE59300176D1 (de)	1995-06-08	5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
DK0411733T3 (da)	1999-06-28	11-beta-aryl-gona-4,9-dien-3-oner
EE200100125A (et)	2002-06-17	TAN-1057 derivaadid
UA48958C2 (uk)	2002-09-16	9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
FI954931L (fi)	1995-11-20	Uusia piperidinyylitioindolin johdannaisia, niiden valmistusmenetelmä, niitä sisältäviä farmaseuttisia koostumuksia, jotka ovat käyttökelpoisia erityisesti kivun lievittäjinä
DK0916663T3 (da)	2003-07-28	18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........
MX9604762A (es)	1997-04-30	Nuevas sulfonamidas y procedimiento para su preparacion.
DE3576505D1 (de)	1990-04-19	3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
DE3578597D1 (de)	1990-08-16	4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FI915875L (fi)	1992-06-15	Menetelmä yleisen kaavan I mukaisten lääkeaineina käyttökelpoisten 2,3-dihydro-4H-1,3-bentsoksatsinon-4-onien ja 2,3-dihydro-4H-bentsotiatsinon-4-onien nitro-oksijohdannaisten valmistamiseksi
DE69327693D1 (de)	2000-03-02	Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen
KR950703559A (ko)	1995-09-20	신규한 축합 티아졸 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물(Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same)
FI903701A0 (fi)	1990-07-23	Reninhaemmande amino-oligohydroxiderivat.
DE59003446D1 (de)	1993-12-16	13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.